Key result
In a 2-week-old preterm boy with possible arthrogryposis multiplex congenita, maternal antibodies were associated with activated complement deposition at most neuromuscular endplates.
Case Report (n=1)
This case report demonstrates endplate destruction due to maternal antibodies in a preterm infant with arthrogryposis multiplex congenita.
Answers are grounded in this paper and cite their sources.
Supports maternal antibody role in neonatal arthrogryposis endplate injury; hypothesis-generating and should not yet change practice.
Arthrogryposis multiplex congenita (AMC) is defined by congenital contractures of 2 or more major joints1 and thought to be caused by prolonged fetal immobility, probably regardless of the underlying cause. It is one typical sign of the fetal akinesia deformation sequence (FADS) or Pena-Shokeir syndrome.2 Among the underlying conditions, 2 are known fetal myasthenic syndromes involving the γ-subunit of the fetal nicotinergic acetylcholine receptor (AChR): mutations in the CHRNG gene encoding the γ-subunit3 and placental transfer of maternal antibodies specific for γ-subunit-containing fetal AChR.4 Because the γ-subunit is replaced by adult-specific e before birth,5 these antibodies do not to cause myasthenic symptoms in the newborn. The mother may be unaffected if she does not have significant antibodies to the adult AChR.6 ### Case report. Muscle biopsy (vastus lateralis) of a 2-week-old preterm (32nd week) boy was sent for diagnostic evaluation for possible AMC. A previous pregnancy had been aborted at the 26th week due to signs of FADS. Standard histology showed immaturity roughly in accord with gestational age (see e-Methods in appendix e-1 and figure e-1, A and B, on the Neurology ® Web site at www.neurology.org), without signs of other disease processes. Staining for cholinesterase and with rhodamine-conjugated α-bungarotoxin, reacting with the α-subunit of both adult and fetal AChR, demonstrated normal reactivities at the neuromuscular endplates (figure, A and E). Double immunolabeling with monoclonal antibodies against the AChR γ-subunit and the membrane attack complex (C5b9; e-Methods) detected activated complement deposition at most endplates …
No takes yet. Share an insight, caveat, or question.
Reimann et al. (2009) conducted a case report in Arthrogryposis multiplex congenita (n=1). Maternal antibodies specific for fetal AChR was evaluated on Activated complement deposition at neuromuscular endplates. In a 2-week-old preterm boy with possible arthrogryposis multiplex congenita, maternal antibodies were associated with activated complement deposition at most neuromuscular endplates.
Synapse has enriched 10 related papers. Consider them for comparative context: